Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1

被引：36
|
作者：
Fernandez-Martinez, Ana B. [1 ]
Bajo, Ana M. [1 ]
Isabel Arenas, M. [2 ]
Sanchez-Chapado, Manuel [3 ,4 ]
Prieto, Juan C. [1 ]
Carmena, Maria J.
机构：
[1] Univ Alcala de Henares, Dept Biochem & Mol Biol, Alcala De Henares 28871, Spain
[2] Univ Alcala de Henares, Dept Cell Biol & Genet, Alcala De Henares 28871, Spain
[3] Univ Alcala de Henares, Dept Surg, Alcala De Henares 28871, Spain
[4] Principe Asturias Hosp, Dept Urol, Alcala De Henares 28871, Spain
来源：
CANCER LETTERS | 2010年 / 299卷 / 01期
关键词：
VIP; RWPE-1; cells; EMT; Tumorigenesis; Prostate cancer; PROTEIN-COUPLED RECEPTORS; MESENCHYMAL TRANSITION; NEUROENDOCRINE DIFFERENTIATION; ANTAGONISTIC ACTION; ANDROGEN RECEPTOR; HORMONE GHRH; CANCER CELLS; EXPRESSION; METASTASIS; APOPTOSIS;
D O I：
10.1016/j.canlet.2010.07.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The carcinogenic potential of vasoactive intestinal peptide (VIP) was analyzed in non-tumor human prostate epithelial cells (RWPE-1) and in vivo xenografts VIP induced morphological changes and a migratory phenotype consistent with stimulation of expression/activity of metalloproteinases MMP-2 and MMP 9 decreased E cadherin-mediated cell-cell adhesion and increased cell motility VIP increased cyclin D1 expression and cell proliferation that was blocked after VPAC(1)-receptor siRNA transfection Similar effects were seen in RWPE-1 tumors developed by subcutaneous injection of VIP-treated cells in athymic nude mice VIP acts as a cytokine in RWPE 1 cell transformation conceivably through epithelial-mesenchymal transition (EMT) reinforcing VIP role in prostate tumorigenesis (C) 2010 Elsevier Ireland Ltd All rights reserved
引用
收藏
页码：11 / 21
页数：11
相关论文
共 50 条
  • [21] Effects of Artesunate with Paclitaxel on the Proliferation and Morphology of Androgen-sensitive (LNCaP), Androgen-insensitive (PC-3) Human Prostate Cancer Cell Lines and Normal Epithelial Prostate cell line (RWPE-1)
    Adedeji, Dolapo
    Fabian, Juan
    Adedeji, Adetayo
    Payne, Gloria
    FASEB JOURNAL, 2020, 34
  • [22] Generation of monoclonal antibodies to human vasoactive intestinal peptide (VIP) 1 receptors.
    Sreedharan, SP
    Pillai, N
    Mu, Y
    Kong, Y
    Goetzl, EJ
    FASEB JOURNAL, 1998, 12 (04): : A153 - A153
  • [23] Vasoactive intestinal peptide (VIP) decreases proliferation of a colon carcinoma epithelial cell line by inducing apoptosis with implications for lymphoid cells.
    Landau, SB
    WoodcockMitchell, J
    GASTROENTEROLOGY, 1996, 110 (04) : A945 - A945
  • [24] Vasoactive intestinal peptide (VIP) suppresses the metastasis potential of human clear cell renal cell carcinoma
    Carmena, M. J.
    Oliva, E. V.
    Chueca, A. M. B.
    Chapado, M. S.
    Prieto, J. C.
    FEBS JOURNAL, 2012, 279 : 139 - 139
  • [25] VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) INDUCES CALCIUM MOBILIZATION IN THE HUMAN NEUROBLASTOMA CELL-LINE SK-N-SH
    OETTLING, G
    BRUCHELT, G
    LOHMANN, F
    TEUFEL, M
    NIETHAMMER, D
    TREUNER, J
    DREWS, U
    CANCER LETTERS, 1990, 50 (03) : 203 - 207
  • [26] HT-29, A MODEL CELL-LINE - STIMULATION BY THE VASOACTIVE INTESTINAL PEPTIDE (VIP) - VIP RECEPTOR STRUCTURE AND METABOLISM
    MARCHISMOUREN, G
    MARTIN, JM
    LUIS, J
    ELBATTARI, A
    MULLERR, JM
    MARVALDI, J
    PICHON, J
    BIOCHIMIE, 1988, 70 (05) : 663 - 671
  • [27] The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response
    Conte, Maria P.
    Aleandri, Marta
    Marazzato, Massimiliano
    Conte, Antonietta L.
    Ambrosi, Cecilia
    Nicoletti, Mauro
    Zagaglia, Carlo
    Gambara, Guido
    Palombi, Fioretta
    De Cesaris, Paola
    Ziparo, Elio
    Palamara, Anna T.
    Riccioli, Anna
    Longhi, Catia
    INFECTION AND IMMUNITY, 2016, 84 (11) : 3105 - 3113
  • [28] Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells
    Valdehita, Ana
    Bajo, Ana M.
    Schally, Andrew V.
    Varga, Jozsef L.
    Carmena, Maria J.
    Prieto, Juan C.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 302 (01) : 41 - 48
  • [29] Malignant transformation in a nontumorigenic human prostatic epithelial cell line
    Hayward, SW
    Wang, YH
    Cao, M
    Hom, YK
    Zhang, BH
    Grossfeld, GD
    Sudilovsky, D
    Cunha, GR
    CANCER RESEARCH, 2001, 61 (22) : 8135 - 8142
  • [30] VASOACTIVE INTESTINAL PEPTIDE (VIP) CONTROL OF GLYCOGENOLYSIS IN THE HUMAN-COLON CARCINOMA CELL-LINE HT-29 IN CULTURE
    ROUSSET, M
    LABURTHE, M
    CHEVALIER, G
    BOISSARD, C
    ROSSELIN, G
    ZWEIBAUM, A
    FEBS LETTERS, 1981, 126 (01) : 38 - 40
12345